AU2001296466A1 - Kini-3 motor protein and methods for its use - Google Patents

Kini-3 motor protein and methods for its use

Info

Publication number
AU2001296466A1
AU2001296466A1 AU2001296466A AU9646601A AU2001296466A1 AU 2001296466 A1 AU2001296466 A1 AU 2001296466A1 AU 2001296466 A AU2001296466 A AU 2001296466A AU 9646601 A AU9646601 A AU 9646601A AU 2001296466 A1 AU2001296466 A1 AU 2001296466A1
Authority
AU
Australia
Prior art keywords
kini
methods
motor protein
protein
motor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296466A
Inventor
Christophe Beraud
Katherine A. Davies
Richard Freedman
Jun Guo
Umesh A. Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytokinetics Inc
Original Assignee
Cytokinetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytokinetics Inc filed Critical Cytokinetics Inc
Publication of AU2001296466A1 publication Critical patent/AU2001296466A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/914—Protein engineering
AU2001296466A 2000-09-29 2001-09-28 Kini-3 motor protein and methods for its use Abandoned AU2001296466A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/675,227 US6461855B1 (en) 2000-09-29 2000-09-29 Motor proteins and methods for their use
US09675227 2000-09-29
PCT/US2001/030750 WO2002026929A2 (en) 2000-09-29 2001-09-28 Kini-3 motor protein and methods for its use

Publications (1)

Publication Number Publication Date
AU2001296466A1 true AU2001296466A1 (en) 2002-04-08

Family

ID=24709566

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001296466A Abandoned AU2001296466A1 (en) 2000-09-29 2001-09-28 Kini-3 motor protein and methods for its use

Country Status (6)

Country Link
US (6) US6461855B1 (en)
EP (1) EP1330535A4 (en)
JP (1) JP2004509639A (en)
AU (1) AU2001296466A1 (en)
CA (1) CA2423955A1 (en)
WO (1) WO2002026929A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2413013A1 (en) * 2000-06-15 2001-12-20 Cytokinetics, Inc. Novel motor proteins and methods for their use
US6461855B1 (en) * 2000-09-29 2002-10-08 Cytokinetics, Inc. Motor proteins and methods for their use
US20070134660A1 (en) * 2003-05-30 2007-06-14 Rosetta Inpharmatics Llc Methods for identifying modulators of kinesin activity
US7618981B2 (en) 2004-05-06 2009-11-17 Cytokinetics, Inc. Imidazopyridinyl-benzamide anti-cancer agents
US20100093767A1 (en) * 2004-12-03 2010-04-15 Takeda San Diego, Inc. Mitotic Kinase Inhibitors
US20090264316A1 (en) * 2008-04-17 2009-10-22 Marshall University Research Corporation Ultraviolet/Ozone Patterned Organosilane Surfaces
EP2582682B1 (en) 2010-06-17 2015-01-14 Cytokinetics, Inc. Mitotic kinesin inhibitors for use in the treatmetnof pulmonary arterial hypertension
JP6231857B2 (en) * 2012-11-13 2017-11-15 徳人 ▲高▼村 Ophthalmic combination that enhances the effect of drugs with binding affinity for albumin in aqueous humor
CN104166686B (en) * 2014-07-28 2017-10-13 北京中科启信软件技术有限公司 Database Systems, main frame and application method based on PCI or PCIE boards
SE540702C2 (en) 2017-02-08 2018-10-16 Teknik Support M Bertilsson Ab Apparatus and method for cleaning melt spouts and melt discharge openings of a chemical recovery furnace or boiler

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1049475A4 (en) 1998-01-08 2003-06-04 Univ California KINESIN MOTOR MODULATORS DERIVED FROM THE MARINE SPONGE $i(ADOCIA)
AU3745799A (en) * 1998-04-14 1999-11-01 Regents Of The University Of California, The Assays for the detection of microtubule depolymerization inhibitors
WO2001064835A2 (en) * 2000-02-28 2001-09-07 Hyseq, Inc. Novel nucleic acids and polypeptides
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
US6294371B1 (en) * 2000-07-21 2001-09-25 Cytokinetics, Inc. Motor proteins and methods for their use
US6461855B1 (en) * 2000-09-29 2002-10-08 Cytokinetics, Inc. Motor proteins and methods for their use

Also Published As

Publication number Publication date
US6461855B1 (en) 2002-10-08
US20030036075A1 (en) 2003-02-20
CA2423955A1 (en) 2002-04-04
US6436686B1 (en) 2002-08-20
US6794178B2 (en) 2004-09-21
WO2002026929A3 (en) 2002-06-13
US6432659B1 (en) 2002-08-13
US6514738B1 (en) 2003-02-04
WO2002026929A2 (en) 2002-04-04
EP1330535A4 (en) 2005-01-26
US20050054041A1 (en) 2005-03-10
JP2004509639A (en) 2004-04-02
EP1330535A2 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
AU2001232799A1 (en) Protein c derivatives
AU2001288249A1 (en) Biosensors and methods for their use
AU2001253418A1 (en) Compounds and methods
AU2001243394A1 (en) Compounds and methods
AU2001286721A1 (en) Human interleukin-four induced protein
AU2001296466A1 (en) Kini-3 motor protein and methods for its use
AUPQ872300A0 (en) Compounds and methods
AU2001281002A1 (en) Motor proteins and methods for their use
AU2001274566A1 (en) Novel protein and dna thereof
AU2001283207A1 (en) Novel motor proteins and methods for their use
AU2001266961A1 (en) Novel motor proteins and methods for their use
AU2001278951A1 (en) Compounds and methods
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2001297707A1 (en) Motor proteins and methods for their use
AU2001264726A1 (en) Novel motor proteins and methods for their use
AU2136401A (en) P450rai-2 and related proteins
AU2001274676A1 (en) Plant-signalling ligand like proteins
AU2002216100A1 (en) Dormancy - induced mycobacterium proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2002256556A1 (en) Sea-trosy and related methods
AU2001280993A1 (en) Tissue-associated proteins and their uses
AU2002235277A1 (en) Compounds and methods
AU2001268099A1 (en) Novel motor proteins and methods for their use
AU2001268637A1 (en) Novel motor proteins and methods for their use